Headlands Technologies LLC Tg Therapeutics, Inc. Transaction History
Headlands Technologies LLC
- $834 Million
- Q3 2024
A detailed history of Headlands Technologies LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 3,642 shares of TGTX stock, worth $117,272. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,642
Previous 6,980
47.82%
Holding current value
$117,272
Previous $124,000
31.45%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
338Shares Held
87.7MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$495 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$367 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$293 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$115 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$103 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.68B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...